Molecular Characterization and Outcomes of Aggressive B-Cell Lymphomas.

555 participants · First posted Sep 18, 2025

Acalabrutinib + Liso-Cel In R/R Aggressive B-Cell Lymphomas

28 participants · First posted Oct 17, 2022

Metronomic Chemotherapy in Elderly Non-fit Patients With Aggressive B-Cell Lymphomas

21 participants · First posted May 19, 2017

Pixantrone(Pixuvri)

C₁₇H₁₉N₅O₂

dual anti-CD19/anti-CD20 CAR T-cells (chronic lymphocytic leukemia/B-cell lymphomas)

4SCAR19U T cell therapy (B-cell acute lymphoblastic leukemia/B-cell lymphoma)

AB&B BIO-TECH-B

Gamida Cell

Israel

GAMIDA CELL INC.

United States

Tafasitamab-Lenalidomide Combination Reduces Disease Progression Risk by 25% in High-Risk Aggressive B-Cell Lymphomas

Ultrasensitive DNA Detection Shows Promise in B-Cell Lymphoma Remission Assessment

Genmab's Epcoritamab Shows Promise in Diffuse Large B-Cell Lymphoma Trials